CN106039551A - Catheter device and brachytherapy system - Google Patents
Catheter device and brachytherapy system Download PDFInfo
- Publication number
- CN106039551A CN106039551A CN201610431937.3A CN201610431937A CN106039551A CN 106039551 A CN106039551 A CN 106039551A CN 201610431937 A CN201610431937 A CN 201610431937A CN 106039551 A CN106039551 A CN 106039551A
- Authority
- CN
- China
- Prior art keywords
- fluid flow
- node unit
- outer layer
- flow tubes
- pipe guide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002725 brachytherapy Methods 0.000 title claims abstract description 29
- 206010028980 Neoplasm Diseases 0.000 claims abstract description 75
- 239000012530 fluid Substances 0.000 claims abstract description 58
- 238000001959 radiotherapy Methods 0.000 claims description 18
- 238000003384 imaging method Methods 0.000 claims description 15
- 230000029058 respiratory gaseous exchange Effects 0.000 claims description 8
- 230000001225 therapeutic effect Effects 0.000 claims description 6
- 238000002591 computed tomography Methods 0.000 claims description 3
- 240000002853 Nelumbo nucifera Species 0.000 claims 4
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims 4
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims 4
- 239000012634 fragment Substances 0.000 claims 4
- 238000005481 NMR spectroscopy Methods 0.000 claims 2
- 238000002600 positron emission tomography Methods 0.000 claims 1
- 230000005855 radiation Effects 0.000 description 43
- 238000011282 treatment Methods 0.000 description 39
- 210000001519 tissue Anatomy 0.000 description 33
- 238000010586 diagram Methods 0.000 description 25
- 230000000694 effects Effects 0.000 description 21
- 238000003325 tomography Methods 0.000 description 12
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 11
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 11
- 230000008602 contraction Effects 0.000 description 11
- 201000004101 esophageal cancer Diseases 0.000 description 11
- 230000006378 damage Effects 0.000 description 9
- 208000015634 Rectal Neoplasms Diseases 0.000 description 7
- 238000013461 design Methods 0.000 description 7
- 206010038038 rectal cancer Diseases 0.000 description 7
- 201000001275 rectum cancer Diseases 0.000 description 7
- 238000002560 therapeutic procedure Methods 0.000 description 7
- 238000000034 method Methods 0.000 description 6
- 230000004614 tumor growth Effects 0.000 description 6
- 210000003238 esophagus Anatomy 0.000 description 5
- 210000000214 mouth Anatomy 0.000 description 5
- 210000000056 organ Anatomy 0.000 description 5
- 210000004881 tumor cell Anatomy 0.000 description 5
- 206010002091 Anaesthesia Diseases 0.000 description 4
- 239000002390 adhesive tape Substances 0.000 description 4
- 230000036586 afterload Effects 0.000 description 4
- 230000037005 anaesthesia Effects 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000003780 insertion Methods 0.000 description 4
- 230000037431 insertion Effects 0.000 description 4
- 208000032843 Hemorrhage Diseases 0.000 description 3
- 239000000853 adhesive Substances 0.000 description 3
- 230000001070 adhesive effect Effects 0.000 description 3
- 239000000560 biocompatible material Substances 0.000 description 3
- 208000034158 bleeding Diseases 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 238000006073 displacement reaction Methods 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 210000000436 anus Anatomy 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- 238000002710 external beam radiation therapy Methods 0.000 description 2
- 239000011796 hollow space material Substances 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 239000004816 latex Substances 0.000 description 2
- 229920000126 latex Polymers 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 210000003928 nasal cavity Anatomy 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 239000004810 polytetrafluoroethylene Substances 0.000 description 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 2
- 230000002285 radioactive effect Effects 0.000 description 2
- 210000000664 rectum Anatomy 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- 230000009747 swallowing Effects 0.000 description 2
- 238000011287 therapeutic dose Methods 0.000 description 2
- 210000000115 thoracic cavity Anatomy 0.000 description 2
- 208000003174 Brain Neoplasms Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010014733 Endometrial cancer Diseases 0.000 description 1
- 206010014759 Endometrial neoplasm Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 208000001894 Nasopharyngeal Neoplasms Diseases 0.000 description 1
- 206010061306 Nasopharyngeal cancer Diseases 0.000 description 1
- 208000012868 Overgrowth Diseases 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 206010037765 Radiation pneumonitis Diseases 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 235000012489 doughnuts Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 238000002594 fluoroscopy Methods 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 238000002595 magnetic resonance imaging Methods 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000002200 mouth mucosa Anatomy 0.000 description 1
- 238000013421 nuclear magnetic resonance imaging Methods 0.000 description 1
- 238000011369 optimal treatment Methods 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 229940125723 sedative agent Drugs 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000014860 sensory perception of taste Effects 0.000 description 1
- 238000002603 single-photon emission computed tomography Methods 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- 230000002966 stenotic effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
- A61N5/1007—Arrangements or means for the introduction of sources into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
- A61N5/1002—Intraluminal radiation therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/103—Treatment planning systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/1048—Monitoring, verifying, controlling systems and methods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
- A61N5/1007—Arrangements or means for the introduction of sources into the body
- A61N2005/1008—Apparatus for temporary insertion of sources, e.g. afterloaders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/1048—Monitoring, verifying, controlling systems and methods
- A61N5/1049—Monitoring, verifying, controlling systems and methods for verifying the position of the patient with respect to the radiation beam
- A61N2005/1052—Monitoring, verifying, controlling systems and methods for verifying the position of the patient with respect to the radiation beam using positron emission tomography [PET] single photon emission computer tomography [SPECT] imaging
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/1048—Monitoring, verifying, controlling systems and methods
- A61N5/1049—Monitoring, verifying, controlling systems and methods for verifying the position of the patient with respect to the radiation beam
- A61N2005/1055—Monitoring, verifying, controlling systems and methods for verifying the position of the patient with respect to the radiation beam using magnetic resonance imaging [MRI]
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Radiation-Therapy Devices (AREA)
Abstract
Description
技术领域technical field
本发明涉及一种用于近接放射治疗的导管装置,尤其涉及具有可胀缩元件的近接放射治疗导管装置及近接放射治疗系统。The invention relates to a catheter device for brachytherapy, in particular to a brachytherapy catheter device with expandable and contractable elements and a brachytherapy system.
背景技术Background technique
放射治疗可分做两大类,分别是体外放射治疗及近接放射治疗(近接治疗),肿瘤的近接治疗是利用导管进入体腔或器官,将导管靠近肿瘤组织周围,再利用后荷式治疗仪,将射源输送进入导管,使射源所放出的放射线近距离照射肿瘤区域,让其光波或高速粒子型态传送的高能量放射线,破坏肿瘤细胞,抑制肿瘤细胞生长的一种技术。近接治疗特别适合用于生长在体腔内的肿瘤,例如食道癌、子宫颈癌、子宫内膜癌、鼻咽癌、肺癌、直肠癌,及其他具管腔可以置放导管的肿瘤。另外,近接治疗亦可藉由组织插针的方式用于非管腔的肿瘤,例如摄护腺癌、乳癌、恶性肉瘤、脑瘤等。Radiation therapy can be divided into two categories, namely external beam radiation therapy and brachytherapy (brachytherapy). Brachytherapy for tumors is to use catheters to enter body cavities or organs, place the catheters close to the tumor tissue, and then use post-loading therapy equipment. It is a technology to transport the radiation source into the catheter so that the radiation emitted by the radiation source can irradiate the tumor area at close range, and let the high-energy radiation transmitted in the form of light waves or high-speed particles destroy tumor cells and inhibit the growth of tumor cells. Brachytherapy is especially suitable for tumors growing in body cavities, such as esophageal cancer, cervical cancer, endometrial cancer, nasopharyngeal cancer, lung cancer, rectal cancer, and other tumors with lumens for catheter placement. In addition, brachytherapy can also be used for non-luminal tumors, such as prostate cancer, breast cancer, malignant sarcoma, brain tumor, etc., by means of tissue insertion.
在进行体外放射治疗或近接放射治疗时,皆会使肿瘤周围的正常组织因照受到放射线而产生副作用。以皮肤为例,在经常摩擦的部位,如腋下、胯下等,经放射线照射以后容易发炎破皮。腹部接受放射线治疗则常有腹泻副作用。头颈部放射线治疗可能会出现唾液变粘稠、唾液减少、味觉改变、口腔粘膜红肿、口干、吞咽疼痛困难,甚至胃口丧失等等情形。胸腔放射线治疗可能产生放射性肺炎、食道发炎等,甚至食道急性出血。因此,放射治疗最理想的情况为给予足以使肿瘤细胞致死的剂量,同时保护正常组织。When performing external beam radiation therapy or brachytherapy, the normal tissues around the tumor will be exposed to radiation and cause side effects. Taking the skin as an example, areas that are often rubbed, such as underarms and crotch, are prone to inflammation and broken skin after radiation exposure. Radiation therapy to the abdomen is often associated with diarrhea as a side effect. Radiation therapy to the head and neck may result in thickened saliva, decreased saliva, altered sense of taste, redness and swelling of the oral mucosa, dry mouth, difficulty swallowing, and even loss of appetite. Chest radiation therapy may produce radiation pneumonitis, esophageal inflammation, etc., and even acute bleeding of the esophagus. Therefore, the ideal situation of radiation therapy is to deliver a dose sufficient to kill tumor cells while sparing normal tissues.
放射线治疗的副作用发生,与接受放射线照射部位及照射的剂量有关。以近接治疗为例,正常组织距离射源愈近,则正常组织所吸收剂量愈高,副作用则愈大。因放射源强度度会随距离平方成反比递减。故近接治疗的最佳剂量是以可杀死肿瘤细胞,却又不造成正常组织的伤害的剂量。如图1(Hitoshi Ikushima,Radiation therapy:state of theart and the future,The Journal of Medical Investigation Vol.57February 2010)所示。目前多以改善剂量顺性度(dose conformity)和均匀度(dose homogeneity)的方式来提高肿瘤治疗剂量,并减少正常组织放射线照射的剂量和范围(使图1中正常组织毒性曲线向右位移),以提升治愈率并减少正常组织毒性。而由于各个病患体腔/器官与肿瘤大小皆不一样,能依照每个病患其正常组织、肿瘤与放射源情况而提供最佳的治疗剂量,是临床上个人化医疗最大的困难。加上体内器官会随着呼吸有自然的内部位移(internalmovement),例如在吸气时,横膈膜下降胸腔胀大,所有位于胸腔内的脏器都会因呼吸而移动,造成放射治疗不精确,因此治疗时需要将位移的偏差也考虑进去,如图2(HitoshiIkushima,Radiation therapy:state of the art and the future,The Journal ofMedical Investigation Vol.57February 2010)中肿瘤大小GTV(Gross tumor volume)即肿瘤在影像中的大小位置;扩散范围CTV(Clinical target volume)为肿瘤可能的扩散范围;移动偏差范围ITV(Internal target volume)则包含内部位移的偏差范围;治疗边界范围PTV(Planning target volume)为治疗计划中的边界范围。由于体外放疗或其他在外部固定的近接治疗方式,都无法精确将放射源与肿瘤相对固定,因此会让额外的正常组织受到放射剂量(ITV、PTV范围),另一方面,近接治疗需要进行数次疗程,需要精确的定位以确保每次疗程肿瘤都接受到一致的治疗剂量,维持治疗的一致性与再现性。The occurrence of side effects of radiation therapy is related to the site of radiation exposure and the dose of radiation. Taking brachytherapy as an example, the closer the normal tissue is to the radiation source, the higher the dose absorbed by the normal tissue and the greater the side effects. Because the intensity of the radioactive source will decrease inversely proportional to the square of the distance. Therefore, the optimal dose of brachytherapy is the dose that can kill tumor cells without causing damage to normal tissues. As shown in Figure 1 (Hitoshi Ikushima, Radiation therapy: state of the art and the future, The Journal of Medical Investigation Vol.57February 2010). At present, the way of improving dose conformity and homogeneity is mostly used to increase the dose of tumor treatment, and reduce the dose and range of radiation exposure to normal tissues (shifting the normal tissue toxicity curve to the right in Figure 1). , to increase cure rates and reduce normal tissue toxicity. Since each patient's body cavity/organ and tumor size are different, it is the biggest difficulty in clinical personalized medicine to provide the optimal treatment dose according to each patient's normal tissue, tumor and radiation source conditions. In addition, the organs in the body will have a natural internal movement with breathing. For example, when inhaling, the diaphragm descends and the chest cavity expands. All organs in the chest cavity will move due to breathing, resulting in inaccurate radiation therapy. Therefore, it is necessary to take into account the displacement deviation during treatment, as shown in Figure 2 (Hitoshi Ikushima, Radiation therapy: state of the art and the future, The Journal of Medical Investigation Vol.57February 2010), the tumor size GTV (Gross tumor volume) is the tumor in The size and position in the image; the spread range CTV (Clinical target volume) is the possible spread range of the tumor; the movement deviation range ITV (Internal target volume) includes the deviation range of internal displacement; the treatment boundary range PTV (Planning target volume) is the treatment plan The boundary range in . Since external radiotherapy or other externally fixed brachytherapy methods cannot accurately fix the radiation source relative to the tumor, additional normal tissues will be exposed to radiation doses (ITV, PTV range). On the other hand, brachytherapy requires several For each course of treatment, precise positioning is required to ensure that the tumor receives a consistent therapeutic dose in each course of treatment and maintain the consistency and reproducibility of treatment.
为了使得放射线剂量在患部的分布较为均匀,并避免副作用,导管装置发展出了加粗管径,使射源置于导管中间的方式。将加粗导管置入体腔后,使得周边组织与射源的距离相同。例如Elekta的Bonvoisin-Gerard Esophageal Applicator产品,该导管即是以整段导管加粗的方式撑开体腔以利给予射源。然而整段加粗虽有射源置中功能,但肿瘤的形状不一,不同区段的肿瘤生长的大小不同,整段导管以同样的幅度加粗,因射源的剂量和距离平方成反比,当一部分肿瘤生长仅限于表浅处时,被照射到的正常组织部位便较多,引发副作用。而在肿瘤较大而狭窄严重的地方,以同样的大小撑开,可能造成管壁摩擦狭窄的食道壁肿瘤而导致出血,使患者感到不适。且因食道是平滑又会蠕动的器官,若使用整段导管加粗而无起伏的管材,容易造成导管滑动,固定效果不佳。In order to make the distribution of radiation dose in the affected area more uniform and avoid side effects, the catheter device has developed a way to increase the diameter of the catheter so that the radiation source is placed in the middle of the catheter. After placing the thickened catheter into the body cavity, the distance between the surrounding tissue and the radiation source is the same. For example, Elekta's Bonvoisin-Gerard Esophageal Applicator product, the catheter is to open the body cavity in a way that the entire catheter is thickened to facilitate the administration of the radiation source. However, although the entire segment is thickened to center the radiation source, the shape of the tumor is different, and the size of the tumor growth in different segments is different. The entire segment of the catheter is thickened with the same range, because the dose of the radiation source is inversely proportional to the square of the distance. , when part of the tumor growth is limited to the superficial part, more normal tissue parts are irradiated, causing side effects. However, in a place with a large tumor and severe stenosis, if the tube wall is stretched with the same size, it may cause the tube wall to rub against the stenotic esophageal wall tumor and cause bleeding, which will make the patient feel uncomfortable. And because the esophagus is a smooth and peristaltic organ, if the whole section of the catheter is thickened without ups and downs, it is easy to cause the catheter to slip, and the fixation effect is not good.
Elekta的另一导管Standard Nasopharyngeal Applicator Set,则是将导管置入病人体腔,再以气囊充气撑开体腔,如图3(a)所示,然而在此外加的气囊,在未充气以前呈现皱缩的状态,如图3(b)所示,在进入体腔时会和体腔壁摩擦,可能会造成病患不适感,甚至导致腔壁损伤。Elekta’s other catheter, the Standard Nasopharyngeal Applicator Set, is to place the catheter into the patient’s body cavity, and then inflate the body cavity with a balloon, as shown in Figure 3(a). However, the additional balloon shrinks before it is inflated As shown in Figure 3(b), it will rub against the wall of the body cavity when it enters the body cavity, which may cause discomfort to the patient and even cause damage to the cavity wall.
再以美国专利公告号US6575932B1公开的导管为例,其具有2个气囊,可分别充气,以便在体腔中固定导管;再藉由伸缩两气囊中间的管子决定气囊之间距离,中间管子设有开口可以给药。然而如将此导管用于近接治疗,中间管子供射源通过,若2个气囊中间距离太短,射源仅适合停留在这一小段位置以确保射源置中和剂量均匀。当管腔内有弥漫性肿瘤、肿瘤长度在3公分以上时,需要重复置放导管与放射源,容易造成腔体的受伤,且多次操作耗费大量时间与病患的精神,加上分段剂量衔接相当困难,在邻近两相连照射范围交集处容易会有剂量重迭造成剂量超标,可能造成无法修复的损伤,增加不必要的风险。若2个气囊中间距离拉长,则难以固定整段肿瘤的位置,患者容易因为呼吸或移动,使得导管滑动,改变射源位置,使肿瘤细胞无法得到足够的治疗剂量,且正常组织接受过多剂量造成损伤。Taking the catheter disclosed in US Patent No. US6575932B1 as an example, it has two airbags that can be inflated separately to fix the catheter in the body cavity; the distance between the airbags is determined by stretching the tube in the middle of the two balloons, and the middle tube is provided with an opening Can be administered. However, if this catheter is used for brachytherapy, the middle tube is used for the radiation source to pass through. If the distance between the two balloons is too short, the radiation source is only suitable to stay in this short position to ensure that the radiation source is centered and the dose is uniform. When there is a diffuse tumor in the lumen, and the tumor length is more than 3 cm, it is necessary to repeatedly place the catheter and radiation source, which may easily cause injury to the cavity, and multiple operations consume a lot of time and the patient's energy. Dose connection is quite difficult. Dose overlap is likely to occur at the intersection of two adjacent irradiation ranges, resulting in excessive dose, which may cause irreparable damage and increase unnecessary risks. If the distance between the two airbags is long, it will be difficult to fix the position of the entire tumor. The patient may easily slip the catheter due to breathing or movement, changing the position of the radiation source, so that the tumor cells cannot receive enough therapeutic dose, and normal tissues receive too much Doses cause damage.
中国专利公开号CN202387089U的导管的设计,即试图达到肿瘤长度在3公分以上时固定肿瘤。此导管具有导管本体、显影环、至少两个球囊、球囊腔、球囊充盈通道、球囊注入口、导丝(导引线)通道、导丝通道注入口。球囊注入口、球囊充盈通道与球囊的数量相同。球囊直径相同,形状为长圆柱形,治疗时先充盈末端球囊,在此基础上依次充盈相邻球囊;从而在末端球囊扩张的基础上,不更换球囊导管即可直接延长球囊整体长度,达到固定肿瘤长度在3公分以上时的肿瘤。然而因需要导引线辅助治疗,增加了操作上的麻烦。且球囊为外加的长圆柱形气囊,充气时一旦充气量不足,或是气球接合导管时黏着处有偏移,都可能使气球不能均匀膨胀,使得射源无法维持在导管的正中心,将降低治疗计划的再现性。The design of the catheter of Chinese Patent Publication No. CN202387089U is to try to fix the tumor when the length of the tumor is more than 3 centimeters. The catheter has a catheter body, a developing ring, at least two balloons, a balloon cavity, a balloon filling channel, a balloon injection port, a guide wire (guide wire) channel, and a guide wire channel injection port. The number of the balloon injection port and the balloon filling channel is the same as that of the balloon. The diameters of the balloons are the same and the shape is a long cylinder. During treatment, the end balloon is filled first, and then the adjacent balloons are filled sequentially on this basis; thus, on the basis of the expansion of the end balloon, the balloon can be extended directly without replacing the balloon catheter. The overall length of the capsule, reaching the tumor when the length of the fixed tumor is more than 3 cm. However, due to the need for guide wires to assist the treatment, it increases the trouble in operation. Moreover, the balloon is an additional long cylindrical airbag. Once the amount of inflation is insufficient during inflation, or the adhesion of the balloon is offset when it is connected to the catheter, the balloon may not inflate evenly, so that the radiation source cannot be maintained at the exact center of the catheter. Reduced reproducibility of treatment plans.
在操作上的困难中,又以食道癌的治疗最容易让病患不适。食道癌近接治疗因为导入很高的辐射治疗剂量,可能会造成急性出血等副作用,因此在临床的使用上必须非常注意。目前临床上多使用鼻胃管进行治疗,但因其直径较细、固定效果差、且无法使射源于管腔置中,鼻胃管会随机贴附在食道壁上,使射源和正常食道壁距离过近而造成剂量过高,产生辐射热点,容易造成严重副作用,影响医师使用意愿。而为了避免严重副作用的发生,美国American Brachytherapy Society提出建议:近接治疗用的管材直径应至少在10mm。Elekta与Varian公司也开发了此种加粗管径的治疗管材,但加粗的管材需要从口腔放入,无法从鼻腔放入,并可能挤压肿瘤。且临床上需要配合肠胃科医师操作,在内视镜辅助下以导引线由口部引导置入体腔。导引线的施放增加了工作程序,且由口腔放入,容易引起呕吐反射或吞咽反应而改变导管位置,更造成患者的不适感,故必须施予镇静剂或麻醉,病患也必须侧躺,增添操作上的不便与风险。然而,取得肿瘤影像资料后,由医生决定病患治疗计划(决定射源停留位置与停留时间),再将病患移到病床准备接受近接治疗,此时只要病患侧躺的弯曲度有变,医师的治疗计划的适用程度就会降低,使治疗不精确。Among the operational difficulties, the treatment of esophageal cancer is the most likely to cause discomfort to patients. Brachytherapy for esophageal cancer may cause side effects such as acute bleeding due to the high dose of radiation therapy, so it must be used with great care in clinical practice. At present, nasogastric tube is often used for treatment in clinic, but because of its small diameter, poor fixation effect, and the inability to center the radiation source in the lumen, the nasogastric tube will be randomly attached to the esophageal wall, making the radiation source consistent with normal The distance between the esophageal wall is too close to cause too high a dose, resulting in radiation hotspots, which are likely to cause serious side effects and affect doctors' willingness to use. In order to avoid the occurrence of serious side effects, the American Brachytherapy Society of the United States proposes that the diameter of the brachytherapy tube should be at least 10 mm. Elekta and Varian have also developed this kind of treatment tubing with thickened diameter, but the thickened tubing needs to be inserted from the mouth instead of the nasal cavity, and may squeeze the tumor. And clinically, it needs to cooperate with gastroenterologists to operate, and with the assistance of endoscope, guide wires are inserted into the body cavity from the mouth. The deployment of the guide wire increases the working procedures, and it is inserted through the mouth, which may easily cause vomiting reflex or swallowing reaction to change the position of the catheter, and cause discomfort to the patient. Therefore, sedatives or anesthesia must be administered, and the patient must also lie on his side. Increase operational inconvenience and risk. However, after obtaining the tumor imaging data, the doctor decides the patient’s treatment plan (determines the location and duration of the radiation source), and then moves the patient to the bed for brachytherapy. At this time, as long as the patient’s lateral curvature changes , the applicability of the doctor's treatment plan will be reduced, making the treatment imprecise.
多气囊的导管还有美国专利公告号US6527692B1提供的一种导管,此导管用于血管内的近接治疗,同样具有两颗以上的气囊且可分别充气/充液,分别充填目的在于固定导管位置的同时,因为其他未使用的气囊可即时缩放,让血液在未治疗的区段可以通过血管而不阻塞。然而其气囊形状为中空环柱状体(donut shape)或螺旋状(spiral shape),外加于导管上,需要充填一定量之气体/液体方能维持具支撑功能之形状,因此在小体积充填的情况下,容易造成充填不均匀而偏移,射源导管无法维持正中心。但如果为维持中空环柱状体或螺旋状的气囊形状,而使气量太大时,若体腔因肿瘤过度生长而狭窄,可能会使病患不适,甚至导致肿瘤破裂出血。且临床上在放置导管时,即使外加于导管的气囊为未膨胀的状态,在置入病患狭窄的腔体时,亦会因为外加气囊的存在而影响置入的顺畅度,在进入体腔时会和体腔壁摩擦而造成病患不适感甚至腔壁损伤。The multi-balloon catheter also has a catheter provided by US Patent No. US6527692B1. This catheter is used for brachytherapy in blood vessels. It also has more than two balloons and can be inflated/filled separately. The purpose of filling separately is to fix the position of the catheter. At the same time, because the other unused balloons can be expanded in real time, allowing blood to pass through the vessel in the untreated segment without obstruction. However, the shape of the balloon is a donut shape or a spiral shape, and it is added to the catheter. A certain amount of gas/liquid needs to be filled to maintain the supporting shape. Therefore, in the case of small volume filling In this case, it is easy to cause uneven filling and offset, and the source tube cannot maintain the center. However, if the air volume is too large to maintain the shape of the hollow cylindrical body or the helical air bag, if the body cavity is narrowed due to the overgrowth of the tumor, it may cause discomfort to the patient, and even cause the tumor to rupture and bleed. And clinically, when placing the catheter, even if the balloon added to the catheter is not inflated, when it is inserted into the narrow cavity of the patient, the smoothness of the insertion will be affected by the existence of the extra balloon. It will rub against the wall of the body cavity, causing discomfort to the patient and even damage to the cavity wall.
美国专利公告号5910101提供的一种导管,同样具有两颗以上的气囊且可分别充气/充液,两颗以上的气囊目的在于即使是血管弯曲处,也可以给予近接治疗,然而近接治疗中最重要的是射源的剂量和距离平方成反比,本导管虽因多气囊设计而给予了在弯曲处施予治疗的可能,同样未能解决充气时一旦充气量不足,或气球接合导管时黏着处有偏移,可能使气球不能均匀膨胀,使得射源无法维持在导管的正中心的问题。同样适用于血管近接治疗的,还有美国专利公告号US7384411B1提供的一种用于近接治疗的导管,该导管为维持血液顺畅通过,在导管上使用了通道结构(communication structure)的设计,通道结构上设有通道,使得导管置入体内后,病患的血液等能够顺畅通过,避免造成血管道阻塞,也可应用于呼吸道的治疗,供病人所需的气体通过。然而该导管要使用气囊时,将其外加在通道结构外围,增加了导管的体积,在进入体腔时,也可能会和体腔壁摩擦造成病患不适感甚至腔壁损伤。A catheter provided by U.S. Patent Publication No. 5910101 also has more than two airbags and can be inflated/filled respectively. The purpose of more than two airbags is to give brachytherapy even to the bend of the blood vessel. What is important is that the dose of the radiation source is inversely proportional to the square of the distance. Although the multi-balloon design of the catheter gives the possibility of giving treatment at the bend, it also fails to solve the problem of insufficient inflation during inflation, or the adhesion of the balloon to the catheter. There is an offset, which can prevent the balloon from inflating evenly, making it impossible to maintain the source in the exact center of the catheter. Also applicable to vascular proximity therapy, there is also a catheter for proximal therapy provided by US Patent Publication No. US7384411B1. In order to maintain the smooth passage of blood, the catheter uses a channel structure (communication structure) design on the catheter. The channel structure There is a channel on it, so that after the catheter is placed in the body, the patient's blood can pass through smoothly, avoiding blockage of the blood vessel, and it can also be used in the treatment of the respiratory tract to allow the gas required by the patient to pass through. However, when the catheter uses a balloon, it is added to the periphery of the channel structure, which increases the volume of the catheter. When it enters the body cavity, it may also rub against the body cavity wall, causing discomfort to the patient or even damage to the cavity wall.
目前导管存在着上述缺点,因此,如何设计出一种可减少正常组织被放射线照射的范围,避免副作用,同时可满足在多个肿瘤,或是弥漫性肿瘤的情况下,不必需要多次操作、耗费大量时间与病患的精力,以及不需要导引线的辅助,避免多次操作,又不以外加气囊或加粗管径达成上述目的,以避免影响置入病患狭窄的腔体时的顺畅度或不适的一种导管,实为目前亟欲解决的课题。At present, catheters have the above-mentioned shortcomings. Therefore, how to design a catheter that can reduce the range of normal tissue irradiated by radiation, avoid side effects, and meet the needs of multiple tumors or diffuse tumors without requiring multiple operations. It takes a lot of time and energy of the patient, and does not require the assistance of a guide wire, avoids multiple operations, and does not add an external balloon or increase the diameter of the tube to achieve the above goals, so as to avoid affecting the patient's narrow cavity. A kind of catheter of smoothness or discomfort is actually a problem to be solved urgently at present.
发明内容Contents of the invention
本案提供一种导管装置,其包括:一管状结构;复数个流体流管结构,各具有一近端方向及一远端方向,且沿着所述管状结构的一第一轴方向设置;复数个节点单元,沿着所述管状结构的所述第一轴方向排列设置,其中每两个相邻所述节点单元之间形成一间段;以及一外层元件,所述外层元件包覆复数个所述节点单元,使两个相邻节点单元之间形成的所述间段形成一空间。This case provides a catheter device, which includes: a tubular structure; a plurality of fluid flow tube structures, each having a proximal direction and a distal direction, and arranged along a first axial direction of the tubular structure; a plurality of node units arranged along the direction of the first axis of the tubular structure, wherein a section is formed between every two adjacent node units; and an outer layer element, the outer layer element covers a plurality of the node units, so that the interval formed between two adjacent node units forms a space.
根据上述构想,其中更具有复数个所述外层元件,复数个所述外层元件各自分别包覆由两个相邻所述节点单元形成的一所述间段,使两个相邻的所述节点单元之间形成的所述间段形成一空间。According to the above idea, there are a plurality of said outer layer elements, and each of the plurality of said outer layer elements respectively wraps a said section formed by two adjacent said node units, so that the two adjacent said node units The intervals formed between the node units form a space.
根据上述构想,其中所述流体流管结构的数量为四个以上;所述节点单元的数量为五个以上;以及所述外层元件的数量为四个以上。According to the above idea, the number of the fluid flow tube structures is more than four; the number of the node units is more than five; and the number of the outer elements is more than four.
根据上述构想,其中所述复数个流体流管结构于所述近端方向上具有一控制元件,所述控制元件用于使所述流体流管结构的所述远端方向连结的所述外层元件,于所述间段位置各自独立胀缩。According to the above concept, wherein said plurality of fluid flow tube structures has a control element in said proximal direction, said control element is used to connect said outer layers of said fluid flow tube structures in said distal direction The components expand and contract independently at the positions of the intervals.
根据上述构想,其中所述复数个流体流管结构于所述近端方向上具有复数个控制元件,复数个所述控制元件各自独立设置于所述复数个流体流管结构的所述近端方向上;所述控制元件用于使使所述流体流管结构的所述远端方向连结的所述外层元件,于所述间段位置各自独立胀缩。According to the above idea, wherein the plurality of fluid flow tube structures have a plurality of control elements in the proximal direction, and the plurality of control elements are independently arranged in the proximal direction of the plurality of fluid flow tube structures Above; the control element is used to independently expand and contract the outer elements connecting the distal ends of the fluid flow pipe structure at the positions of the intervals.
根据上述构想,其中所述节点单元为一中空柱体结构,其中空处供所述管状结构沿着所述第一轴方向通过所述节点单元;且所述中空柱体的柱壁上沿着所述第一轴方向设有一通道,所述通道供所述流体流管结构沿着所述第一轴方向通过所述节点单元。According to the above idea, wherein the node unit is a hollow cylinder structure, wherein the hollow space allows the tubular structure to pass through the node unit along the first axis direction; and the wall of the hollow cylinder is along the A channel is provided in the first axis direction, and the channel allows the fluid flow pipe structure to pass through the node unit along the first axis direction.
根据上述构想,其中所述节点单元的所述中空柱体结构的外部还具有一接着环部;所述外层元件透过所述接着环部与所述节点单元连结,使两个相邻所述节点单元之间形成的所述间段为一密闭空间。According to the above idea, the outside of the hollow cylinder structure of the node unit also has a connecting ring; the outer element is connected to the node unit through the connecting ring, so that two adjacent The interval formed between the node units is a closed space.
根据上述构想,其中还具有一外环结构,使所述外层元件扣合于所述接着环部。According to the above idea, there is also an outer ring structure, so that the outer layer element is fastened to the connecting ring part.
根据上述构想,其中所述节点单元为一中空柱体结构,其中空处供所述管状结构沿着所述第一轴方向通过所述节点单元;且所述中空柱体的柱壁上沿着所述第一轴方向设有一通道,所述通道供所述流体流管结构沿着所述第一轴方向通过所述节点单元;其中所述节点单元的所述中空柱体结构的外部还具有一突出环部;复数个所述外层元件沿着所述第一轴方向接于两个相邻所述节点单元的所述突出环部上,使两个相邻所述节点单元之间形成的所述间段形成一空间。According to the above idea, wherein the node unit is a hollow cylinder structure, wherein the hollow space allows the tubular structure to pass through the node unit along the first axis direction; and the wall of the hollow cylinder is along the A channel is provided in the direction of the first axis, and the channel allows the fluid flow pipe structure to pass through the node unit along the direction of the first axis; wherein the hollow cylinder structure of the node unit also has a A protruding ring portion; a plurality of the outer layer elements are connected to the protruding ring portions of two adjacent node units along the direction of the first axis, so that two adjacent node units form a The intervals form a space.
根据上述构想,其中至少二个所述流体流管结构的长度相异,以使复数个所述流体流管结构各自连通到不同的所述间段。According to the above concept, at least two of the fluid flow pipe structures have different lengths, so that the plurality of the fluid flow pipe structures are connected to different intervals.
根据上述构想,其中复数个所述流体流管结构上还各自具有一开口,其中所述开口位置各自设置于不同的所述间段位置,使得不同的所述流体流管结构透过各自的所述开口将流体送到不同的所述间段。According to the above idea, each of the plurality of fluid flow tube structures also has an opening, wherein the positions of the openings are respectively set at different positions of the intervals, so that the different fluid flow tube structures pass through the respective The openings deliver fluid to the different intervals.
本发明另提供一种近接放射治疗系统,包括:一后荷式治疗仪;一种如上述构想所述的导管装置,接于所述后荷式治疗仪上;以及一放射治疗源,由所述后荷式治疗仪放出所述放射治疗源到所述导管装置的所述管状结构中。The present invention further provides a brachytherapy system, comprising: an afterloading treatment apparatus; a catheter device as described in the above concept, connected to the afterloading treatment apparatus; and a radiotherapy source, composed of The afterload therapy device delivers the radiation therapy source into the tubular structure of the catheter device.
根据上述构想,其中还进一步具有一肿瘤成像仪器,所述后荷式治疗仪根据所述肿瘤成像仪器决定放出所述放射治疗源到所述管状结构的所述间段位置。According to the above idea, it further has a tumor imaging device, and the afterload therapy device decides to release the radiotherapy source to the position of the interval of the tubular structure according to the tumor imaging device.
根据上述构想,其中,所述肿瘤成像仪器包括但不限于X光成像、萤光透视镜、电脑断层扫描、正子断层扫描、单光子发射断层成像、核磁共振成像。According to the above idea, wherein, the tumor imaging equipment includes but not limited to X-ray imaging, fluoroscopy, computerized tomography, positron tomography, single photon emission tomography, and nuclear magnetic resonance imaging.
附图说明Description of drawings
图1为放射治疗的剂量与组织毒性关系图。Figure 1 is a graph showing the relationship between radiation dose and tissue toxicity.
图2为进行体外放疗时放射范围与位移偏差的示意图。Fig. 2 is a schematic diagram of radiation range and displacement deviation during external radiotherapy.
图3(a)为现有技术中导管气囊充气后的示意图。Fig. 3(a) is a schematic diagram of the catheter balloon inflated in the prior art.
图3(b)为现有技术中导管气囊充气前的示意图。Fig. 3(b) is a schematic view before inflation of the catheter balloon in the prior art.
图4为本案导管装置的一实施例的结构示意图。FIG. 4 is a schematic structural view of an embodiment of the catheter device of the present invention.
图5为本案流体流管结构长度各异的实施例的示意图。FIG. 5 is a schematic diagram of an embodiment of the fluid flow tube structure with different lengths in the present invention.
图6(a)为节点单元的立体示意图。Figure 6(a) is a perspective view of a node unit.
图6(b)为节点单元的正面示意图。Figure 6(b) is a schematic front view of the node unit.
图6(c)为节点单元的侧面示意图。Figure 6(c) is a schematic side view of the node unit.
图7(a)为节点单元上有接着环部的实施例的立体示意图。Fig. 7(a) is a three-dimensional schematic diagram of an embodiment in which the node unit has a connecting ring.
图7(b)为节点单元上有接着环部的实施例的正面示意图。Fig. 7(b) is a schematic front view of an embodiment in which the node unit has a connecting ring.
图7(c)为节点单元上有接着环部的实施例的侧面示意图。Fig. 7(c) is a schematic side view of an embodiment in which the node unit has a connecting ring.
图8(a)为外环结构实施例的示意图。Fig. 8(a) is a schematic diagram of an embodiment of the outer ring structure.
图8(b)为节点单元的接着环部接上外环结构的示意图。FIG. 8( b ) is a schematic diagram of the connecting ring part of the node unit connected to the outer ring structure.
图8(c)为节点单元的接着环部接上外环结构的示意图。FIG. 8( c ) is a schematic diagram of the connecting ring part of the node unit connected to the outer ring structure.
图9为节点单元接上外环结构与外层元件的实施例的示意图。FIG. 9 is a schematic diagram of an embodiment in which a node unit is connected to an outer ring structure and outer elements.
图10(a)为节点单元上有突出环部的实施例的立体示意图。Fig. 10(a) is a schematic perspective view of an embodiment with protruding rings on the node unit.
图10(b)为节点单元上有突出环部的实施例的正面示意图。Fig. 10(b) is a schematic front view of an embodiment with protruding rings on the node units.
图10(c)为节点单元上有突出环部的实施例的侧面示意图。Figure 10(c) is a schematic side view of an embodiment with protruding rings on the node unit.
图11为具有突出环部的节点单元接上外层元件的示意图。Fig. 11 is a schematic diagram of a node unit with a protruding ring connected to an outer element.
图12为外层元件膨胀的示意图。Figure 12 is a schematic diagram of expansion of the outer layer element.
图13为本案导管装置的外层元件各自独立胀缩控制大小以达到顺形肿瘤的示意图。FIG. 13 is a schematic diagram showing that the outer elements of the catheter device in this case independently expand and contract to control the size to achieve a conformal tumor.
具体实施方式detailed description
除非另外定义,本文中所使用的所有技术及科学词汇为在此领域具通常知识者所明了的相同意义。Unless defined otherwise, all technical and scientific terms used herein have the same meaning as understood by one of ordinary skill in the art.
本案「一种导管装置」将可透过以下的实施例说明而让在此领域具通常知识者了解其创作精神,并可据以完成。This case "a kind of catheter device" will allow those with common knowledge in this field to understand its creative spirit through the following embodiment descriptions, and can be completed accordingly.
本案的实施并非由下列实施例而限制其实施型态。The implementation of this case is not limited by the following examples.
请见图4本案导管装置10的一实施例示意图,中间有管状结构11,用以放置射源12。复数个流体流管结构13,沿着管状结构11的第一轴方向设置,其中本案实施例的「第一轴方向」,是以导管装置的长边做轴的方向。导管装置10上具有复数个节点单元15,沿着管状结构11的第一轴方向排列设置,其中每两个相邻节点单元15之间形成一间段1a,每间段1a与外层元件14形成一空间1b。复数个流体流管结构13,各自在其远端方向18具有一开口17,以及在其近端方向19各自具有独立的控制元件16,在一些实施例中,控制元件16可为医用帮浦、针筒、或注射其型装置等。控制元件16将流体(图未示)送入流体流管结构13至其开口17,流体自两个相邻的节点单元15之间的间段1a中出现,充入空间1b,使得外层元件14胀缩,达到定位的效果。由于开口17位置各自设置于不同的间段1a位置,使得不同的流体流管结构13透过各自开口17将流体送到不同的间段1a,达到外层元件14各自胀缩以及各自调控胀缩程度。Please refer to FIG. 4 , a schematic diagram of an embodiment of the catheter device 10 in this case. There is a tubular structure 11 in the middle for placing the radiation source 12 . A plurality of fluid flow pipe structures 13 are arranged along the first axis direction of the tubular structure 11, wherein the "first axis direction" in the embodiment of this case refers to the long side of the catheter device as the axis direction. There are a plurality of node units 15 on the catheter device 10, which are arranged along the first axial direction of the tubular structure 11, wherein a section 1a is formed between every two adjacent node units 15, and each section 1a is connected to the outer layer element 14 A space 1b is formed. A plurality of fluid flow tube structures 13 each have an opening 17 in its distal direction 18 and each have an independent control element 16 in its proximal direction 19. In some embodiments, the control element 16 can be a medical pump, Syringes, or injection-type devices, etc. The control element 16 sends fluid (not shown) into the fluid flow pipe structure 13 to its opening 17, and the fluid emerges from the interval 1a between two adjacent node units 15 and fills the space 1b, so that the outer layer element 14 expansion and contraction, to achieve the effect of positioning. Since the positions of the openings 17 are set in different intervals 1a, different fluid flow tube structures 13 can send fluids to different intervals 1a through the respective openings 17, so that the expansion and contraction of the outer layer elements 14 can be controlled separately. degree.
其中管状结构11、流体流管结构13、外层元件14材质柔软且可弯曲,材质可为硅氧树脂(silicone)、乳胶(latex)、塑胶如PVC、PU、PP、PE、PTFE等以及其他生物相容性材料或其组成,并使外层元件14可于充填后膨胀。管状结构11、流体流管结构13可依不同患部设计不同的长度与口径,相邻两节点单元15形成的间段1a,也可依需求设计为不等的距离长度。The tubular structure 11, the fluid flow pipe structure 13, and the outer layer element 14 are made of soft and bendable materials, such as silicone, latex, plastics such as PVC, PU, PP, PE, PTFE, etc. biocompatible material or its composition, and make the outer layer element 14 expandable after filling. The tubular structure 11 and the fluid flow pipe structure 13 can be designed with different lengths and calibers according to different affected parts, and the interval 1a formed by two adjacent node units 15 can also be designed with unequal distances according to requirements.
在用于食道癌的实施例中,导管装置10可设计为长度900-1400mm,较佳为长度900-1200mm。管状结构11外径可设计为2-6mm,较佳为5.3mm,内径可为1-5mm,较佳为2.0-2.1mm,以能够置入协助放入射源的白管(lumencath)(未图式)的大小即可。In an embodiment for esophageal cancer, the catheter device 10 can be designed to have a length of 900-1400 mm, preferably 900-1200 mm. The outer diameter of the tubular structure 11 can be designed to be 2-6mm, preferably 5.3mm, and the inner diameter can be 1-5mm, preferably 2.0-2.1mm, so that it can be inserted into a white tube (lumencath) (not shown) that assists in placing the radiation source. diagram) size.
如果患部为直肠,则导管装置10长度可设计为300-600mm,较佳为400-600mm。管状结构11外径设计可为6-15mm,较佳为10mm,内径可为1-5mm,较佳为2.0-2.1mm,以能够置入协助放入射源的白管(lumencath)(图未示)的大小即可。If the affected part is the rectum, the length of the catheter device 10 can be designed to be 300-600mm, preferably 400-600mm. The outer diameter of the tubular structure 11 can be designed to be 6-15mm, preferably 10mm, and the inner diameter can be 1-5mm, preferably 2.0-2.1mm, so as to be able to insert a white tube (lumencath) that assists in putting the radiation source (not shown in the figure) Shown) the size is enough.
流体流管结构13在一些实施例中与管状结构11的长度相同,至少有一开口17位于不同间段1a。流体流管结构13的内径可为0.2-3mm之间,较佳的内径为0.7mm。在用于食道癌的实施例中,流体流管结构13的中心距离管状结构中心为0.6-3mm,较佳为1.8-1.9mm。在用于直肠癌的实施例中,流体流管结构13的中心距离管状结构中心为2-5mm,较佳为3.9mm。In some embodiments, the fluid flow pipe structure 13 has the same length as the tubular structure 11, and at least one opening 17 is located in different intervals 1a. The inner diameter of the fluid flow pipe structure 13 may be between 0.2-3 mm, preferably 0.7 mm. In the embodiment for esophageal cancer, the distance between the center of the fluid flow pipe structure 13 and the center of the tubular structure is 0.6-3 mm, preferably 1.8-1.9 mm. In the embodiment for rectal cancer, the distance between the center of the fluid flow pipe structure 13 and the center of the tubular structure is 2-5 mm, preferably 3.9 mm.
节点单元15的材质同样可为硅氧树脂(silicone)、乳胶(latex)、塑胶如PVC、PU、PP、PE、PTFE等以及其他生物相容性材料组成,也可进一步加入具有X-ray显影线或加入硫酸钡等显影材料。在用于食道癌的实施例中,节点单元15的长度可为1-15mm,较佳为1-8mm,在用于直肠癌的实施例中,节点单元15的长度可为1-15mm,较佳为5-15mm。The material of the node unit 15 can also be composed of silicone, latex, plastics such as PVC, PU, PP, PE, PTFE, etc. and other biocompatible materials, and can also be further added with X-ray imaging line or add barium sulfate and other developing materials. In the embodiment for esophageal cancer, the length of node unit 15 can be 1-15mm, preferably 1-8mm, in the embodiment for rectal cancer, the length of node unit 15 can be 1-15mm, relatively The best is 5-15mm.
为使管状结构11与节点单元15之间、流体流管结构13与节点单元15之间,以及外层元件14与节点单元15之间完全气密,使外层元件顺利胀缩,可以使用黏着剂(图未示)辅助。In order to make the space between the tubular structure 11 and the node unit 15, between the fluid flow pipe structure 13 and the node unit 15, and between the outer layer element 14 and the node unit 15 completely airtight, so that the outer layer element can expand and contract smoothly, an adhesive can be used. aids (not shown).
在某些实施例中,复数个流体流管结构13可能由单一调控元件(未图式),例如以电脑控制的打气装置,连结多个流体流管结构13,透过阀门,独立控制各远端方向18连结的外层元件14。在用于食道癌的实施例中,外层元件14的长度可为5-20mm,较佳为16.5mm,可选择膨胀至直径30mm或更小。于用于直肠癌的实施例中,外层元件14的长度可为20-50mm,较佳为30mm,可选择膨胀至直径50mm或更小。In some embodiments, a plurality of fluid flow pipe structures 13 may be connected by a single control element (not shown), such as a computer-controlled pumping device, to connect multiple fluid flow pipe structures 13, and independently control each remote through a valve. Outer elements 14 joined end-wise 18 . In an embodiment for esophageal cancer, the outer member 14 may have a length of 5-20 mm, preferably 16.5 mm, optionally expanded to a diameter of 30 mm or less. In an embodiment for rectal cancer, the outer layer member 14 may have a length of 20-50 mm, preferably 30 mm, optionally expanded to a diameter of 50 mm or less.
图5为本案导管装置10的另一种实施例的示意图,其中流体流管结构13的彼此长度各异,使不同的流体流管结构13各自连通到不同的间段1a,充入空间1b,达到外层元件14各自胀缩以及各自调控胀缩程度。5 is a schematic diagram of another embodiment of the catheter device 10 of the present case, wherein the fluid flow pipe structures 13 have different lengths, so that different fluid flow pipe structures 13 are connected to different intervals 1a and filled into the space 1b. To achieve the respective expansion and contraction of the outer layer elements 14 and the respective regulation of the expansion and contraction degree.
图6(a)、图6(b)、图6(c)分别为本案节点单元15的立体示意图、正面示意图、侧面示意图。请参考图2与图6(a)、图6(b)、图6(c),节点单元15为一中空柱体结构,其中空处33可供管状结构11沿着通过节点单元15,在节点单元15的柱壁31上设有通道32,使流体流管结构13可通过节点单元15。使两个相邻的节点单元15之间的间段1a与外层元件14形成的空间1b能够密闭,提供外层元件14因充入流体而胀缩的同时,也能使管状结构11与流体流管结构13通过节点单元15。Fig. 6(a), Fig. 6(b) and Fig. 6(c) are respectively a three-dimensional schematic diagram, a front schematic diagram and a side schematic diagram of the node unit 15 of this case. Please refer to Fig. 2 and Fig. 6 (a), Fig. 6 (b), Fig. 6 (c), node unit 15 is a hollow cylinder structure, wherein empty space 33 can be available for tubular structure 11 to pass node unit 15 along, in The column wall 31 of the node unit 15 is provided with a channel 32 so that the fluid flow pipe structure 13 can pass through the node unit 15 . The space 1b formed by the interval 1a between two adjacent node units 15 and the outer layer element 14 can be sealed, and the outer layer element 14 can be expanded and contracted due to being filled with fluid, and the tubular structure 11 can also be connected with the fluid. The flow pipe structure 13 passes through the node unit 15 .
图7(a)、图7(b)、图7(c)分别为本案节点单元15具有接着环部41的立体示意图、正面示意图、侧面示意图;图8(a)、图8(b)、图8(c)为节点单元的接着环部41接上外环结构51的示意图。在本实施例中接着环部41为一环型凹槽,可与图8(a)的外环结构51结合,如图8(b)、8(c)所示。在一些实施例中,外环结构51可为具弹性紧束力的橡皮圈,或是具弹性的生物相容性材料,或是不具弹性的塑料或金属等。Fig. 7 (a), Fig. 7 (b), Fig. 7 (c) are the three-dimensional schematic diagram, the front schematic diagram, the side schematic diagram that the node unit 15 of this case has the ring portion 41 respectively; Fig. 8 (a), Fig. 8 (b), FIG. 8( c ) is a schematic diagram of connecting the connecting ring portion 41 of the node unit to the outer ring structure 51 . In this embodiment, the connecting ring portion 41 is an annular groove, which can be combined with the outer ring structure 51 of FIG. 8( a ), as shown in FIGS. 8( b ) and 8 ( c ). In some embodiments, the outer ring structure 51 can be a rubber ring with elastic binding force, or an elastic biocompatible material, or an inelastic plastic or metal.
图9为节点单元15接上外环结构51与外层元件14的实施例示意图。如图9所示,相邻的两个节点单元15藉由接着环部41与外环结构51固定外层元件14,并形成一空间1b,使得流体(图未示)进入该空间1b后可使该空间1b的外层元件14胀缩。在此实施例中,外层元件14的数量可为1个,再藉由外环结构51与节点单元15的接着环部41给予的压力分段,达到不同间段1a的外层元件14可以分别胀缩的目的。FIG. 9 is a schematic diagram of an embodiment in which the node unit 15 is connected to the outer ring structure 51 and the outer element 14 . As shown in Figure 9, two adjacent node units 15 fix the outer layer element 14 by connecting the ring portion 41 and the outer ring structure 51, and form a space 1b, so that fluid (not shown) can enter the space 1b The outer layer element 14 of the space 1b is expanded and contracted. In this embodiment, the number of the outer layer element 14 can be one, and then the pressure segments given by the outer ring structure 51 and the connecting ring portion 41 of the node unit 15 can reach the outer layer elements 14 of different intervals 1a. The purpose of expansion and contraction respectively.
在图10的实施例中,节点单元15具有突出环部71,图10(a)、图10(b)、图10(c)分别为本案节点单元15具突出环部71的立体示意图、正面示意图、侧面示意图。图11为节点单元15具有突出环部71时,外层元件14接于突出环部71上的示意图。外层元件14接于两个相邻所述节点单元15的所述突出环部71上,使两个相邻所述节点单元15之间形成的间段1a形成一密闭的空间1b,让外层元件14可因充入流体而胀缩。在此实施例中,外层元件14的数量可为多个,视需求可为4个至16个不等,分别接在不同两个相邻节点单元15之间形成的间段。图8中示意外层元件14以薄膜状包住间段1a,其中外层元件14薄膜厚度最佳可为0.1-2mm之间。在用于食道癌的实施例中,外层元件14的长度可为5-50mm,较佳为5-20mm,于用于直肠癌的实施例中,外层元件14长度可为5-50mm,较佳为20-50mm。In the embodiment of FIG. 10, the node unit 15 has a protruding ring portion 71. FIG. 10(a), FIG. 10(b), and FIG. Schematic, side view. FIG. 11 is a schematic diagram of the outer element 14 connected to the protruding ring portion 71 when the node unit 15 has the protruding ring portion 71 . The outer element 14 is connected to the protruding ring portion 71 of two adjacent node units 15, so that the interval 1a formed between the two adjacent node units 15 forms a closed space 1b, allowing the outer The layer element 14 can expand and contract due to filling with fluid. In this embodiment, the number of outer layer elements 14 can be multiple, ranging from 4 to 16 depending on the requirement, and they are respectively connected to the intervals formed between two different adjacent node units 15 . Fig. 8 shows that the outer layer element 14 wraps the intersection 1a in a film shape, wherein the film thickness of the outer layer element 14 can be preferably between 0.1-2 mm. In the embodiment for esophageal cancer, the length of the outer layer element 14 can be 5-50 mm, preferably 5-20 mm, and in the embodiment for rectal cancer, the length of the outer layer element 14 can be 5-50 mm, Preferably it is 20-50mm.
图12为本案导管装置10的外层元件14可因为节点单元15的存在而各自胀缩的示意图。本案因能独立控制不同的空间1b是否充入流体与各自充入的量,故可独立控制各个外层元件14的胀缩程度,当不同区段的肿瘤生长的大小不同时,可以按病人体腔内肿瘤生长情形的实际需求,在体腔狭窄处(因肿瘤较大或较突出造成)充进较少量的流体膨胀外层元件14,肿瘤生长较为表浅处(食道管腔较不狭窄)则充入较多流体使外层元件14膨胀程度变大,达到用较少放射剂量便可杀死肿瘤的目的,以降低副作用。且外层元件14在接着于导管上时,因有节点单元15的设计,可供外层元件14使用黏着剂(图未示)后精准接合于上,改善了现有技术在外加气囊于导管上时,容易因为黏着处有偏移,而导致气囊充气后不均匀而可能出现辐射热点的问题。FIG. 12 is a schematic diagram showing that the outer elements 14 of the catheter device 10 of the present invention can expand and contract respectively due to the existence of the node units 15 . In this case, because it can independently control whether different spaces 1b are filled with fluid and the amount of each filling, it can independently control the expansion and contraction degree of each outer layer element 14. When the size of tumor growth in different sections is different, it can be adjusted according to the patient's body cavity. According to the actual demand of the tumor growth situation in the body cavity, a small amount of fluid expansion outer layer element 14 is filled in the narrow part of the body cavity (caused by a larger or more prominent tumor), and the superficial part of the tumor growth (the esophageal lumen is less narrow). Filling with more fluid makes the expansion degree of the outer layer element 14 larger, so as to achieve the purpose of killing tumors with less radiation dose, so as to reduce side effects. And when the outer layer element 14 is attached to the catheter, due to the design of the node unit 15, the outer layer element 14 can be accurately bonded to the catheter after using an adhesive (not shown), which improves the prior art in adding a balloon to the catheter When the airbag is inflated, it is easy to cause the airbag to be inflated unevenly due to the offset of the adhesive, which may cause the problem of radiation hot spots.
本案因外层元件14与节点单元15的设计,仅需少量充气量,即可具备膨胀效果,因而在决定膨胀程度时,能够选择较小的膨胀量,改善如图3(b)现有技术充气前的皱缩气囊,需要充入一定量以上的流体才能维持气囊形状的问题。本案也因外层元件14与节点单元15的设计,无须如同先前技术外加气囊,导致进入体腔时会和体腔壁摩擦造成病患不适感甚至腔壁损伤,提升了置入病患狭窄的腔体时的顺畅度。In this case, due to the design of the outer layer element 14 and the node unit 15, only a small amount of inflation is required to have an expansion effect, so when determining the degree of expansion, a smaller expansion amount can be selected to improve the prior art shown in Figure 3 (b). The collapsed airbag before inflation needs to be filled with more than a certain amount of fluid to maintain the shape of the airbag. In this case, due to the design of the outer element 14 and the node unit 15, there is no need to add an airbag as in the previous technology, which will cause discomfort to the patient or even damage the cavity wall when entering the body cavity, which improves the insertion into the narrow cavity of the patient. smoothness of time.
图13为本案导管装置10的外层元件14各自独立胀缩控制大小以达到顺形肿瘤组织101的示意图。在接于后荷式治疗仪103之后,导管装置10(省略部分元件),可顺着肿瘤组织101在管腔中的大小,决定在哪个位置外层元件14需要胀缩,以及胀缩的大小,再放入射源12,进行近接治疗。由于本案导管装置10的外层元件14可各自胀缩,使得导管装置10能够顺形肿瘤组织101,使得为病患安排治疗计划时,能够增加肿瘤组织101的照射范围,降低正常组织102的接受剂量,增加病患治愈率,并降低副作用。FIG. 13 is a schematic diagram of the outer layer elements 14 of the catheter device 10 of the present invention expanding and contracting independently to control the size so as to achieve conformal tumor tissue 101 . After being connected to the afterload therapy device 103, the catheter device 10 (some components omitted) can determine at which position the outer layer component 14 needs to expand and contract, and the size of the expansion and contraction along the size of the tumor tissue 101 in the lumen , put into radiation source 12 again, carry out brachytherapy. Since the outer elements 14 of the catheter device 10 in this case can expand and shrink respectively, the catheter device 10 can conform to the tumor tissue 101, so that when arranging a treatment plan for a patient, the irradiation range of the tumor tissue 101 can be increased and the acceptance rate of the normal tissue 102 can be reduced. dosage, increase the cure rate of patients, and reduce side effects.
其中外层元件14胀缩的位置,以及胀缩的大小是根据肿瘤成像仪器104所拍摄的影像决定,肿瘤成像仪器104包括X光成像、萤光透视镜(fluoroscope)、电脑断层扫描(CTScan)、正子断层扫描(PET)、单光子发射断层成像(SPECT)、核磁共振成像(MRI)等。Wherein the expansion and contraction position of the outer layer element 14, and the size of the expansion and contraction are determined according to the image taken by the tumor imaging instrument 104. , Positron Tomography (PET), Single Photon Emission Tomography (SPECT), Magnetic Resonance Imaging (MRI), etc.
过往的影像定位使用2D平面系统,取正面和侧面两张影像,可能存在空间上的误差,目前已趋向使用电脑断层扫描的立体取向方式,此时导管装置10在管腔内的固定效果便显得非常重要,由于导管装置10顺形肿瘤组织101,导管装置10与肿瘤组织101有近似互相嵌合的效果,具有良好的固定效果,使得治疗计划更为精准,成功解决病患因为呼吸使得导管装置10移动,或是因为进行肿瘤成像照射程序到进行放射源的放置治疗程序中间的移动,降低治疗计划的精准度的问题。In the past, a 2D plane system was used for image positioning, and two images of the front and the side may be taken, which may have spatial errors. At present, it has tended to use the stereoscopic orientation method of computerized tomography. At this time, the fixation effect of the catheter device 10 in the lumen is obvious. Very important, because the catheter device 10 conforms to the shape of the tumor tissue 101, the catheter device 10 and the tumor tissue 101 have a similar fitting effect, which has a good fixation effect, making the treatment plan more accurate, and successfully solving the problem of the patient's breathing. 10 Movement, or because of the movement between the tumor imaging irradiation procedure and the radioactive source placement treatment procedure, the problem of reducing the accuracy of the treatment plan.
综上所述,与习知技术,例如Elekta的Bonvoisin-Gerard EsophagealApplicator产品、Standard Nasopharyngeal Applicator Set产品、美国专利公告号US7384411B1、美国专利公告号US6575932B1、中国专利公开号CN202387089U、美国专利公告号US6527692B1以及美国专利公告号5910101等所公开的导管相比,本案增加了固定效果、减少正常组织被放射线照射的范围,降低副作用,同时因外层元件14藉由外环结构51与节点单元15的接着环部41分段,或是以具备多个外层元件14的方式分段,达到不同间段1a的外层元件14可以分别胀缩,例如具有4-16个可分别胀缩的外层元件14,在多个肿瘤,或是弥漫性肿瘤的情况下,本发明在需要处皆可固定,并单纯依靠移动射源而治疗多个弥漫性癌症区段,不需要多次重复操作耗费大量时间与病患的精力;也因外层元件14胀缩程度、大小可以分别独立控制,使用时可依患部肿瘤的态样,决定不同的外层元件14其各自胀缩的程度、大小,以将整段肿瘤顺形固定,如此即使患者呼吸或移动时产生位移,导管装置10因已顺形固定了肿瘤,可随着肿瘤组织移动而不会滑动,不会造成与肿瘤组织的相对位置改变,增加医师治疗计划的精准度。In summary, with known technologies, such as Elekta's Bonvoisin-Gerard Esophageal Applicator product, Standard Nasopharyngeal Applicator Set product, U.S. Patent No. US7384411B1, U.S. Patent No. US6575932B1, Chinese Patent No. CN202387089U, U.S. Patent No. Compared with the catheters disclosed in Patent Publication No. 5910101, etc., this case increases the fixation effect, reduces the range of normal tissue irradiated by radiation, and reduces side effects. 41 segmented, or segmented with a plurality of outer layer elements 14, the outer layer elements 14 reaching different intervals 1a can be expanded and contracted separately, for example, there are 4-16 outer layer elements 14 that can be expanded and contracted respectively, In the case of multiple tumors or diffuse tumors, the present invention can be fixed where needed, and treat multiple diffuse cancer segments simply by moving the radiation source, without requiring repeated operations to consume a lot of time and disease. Also because the degree of expansion and contraction of the outer layer elements 14 and the size can be independently controlled, the degree and size of the expansion and contraction of different outer layer elements 14 can be determined according to the appearance of the tumor in the affected part during use, so that the entire segment The tumor is fixed in a conformal manner, so that even if the patient moves when breathing or moving, the catheter device 10 has fixed the tumor in a conformal manner, and can move with the tumor tissue without slipping, and will not cause changes in the relative position of the tumor tissue, increasing physician Accuracy of treatment planning.
在任何需要撑开体腔的导管治疗,皆可利用本发明的技术特征,以下将以食道癌与直肠癌的治疗为例,描述施用步骤,辅助所属技术领域中具有通常知识者理解本发明可能的施用方式,并在不超出本案申请专利范围的情况下,替换其他使用步骤施用本发明:The technical features of the present invention can be used in any catheter treatment that requires opening the body cavity. The following will take the treatment of esophageal cancer and rectal cancer as an example to describe the application steps to assist those with ordinary knowledge in the technical field to understand the possible aspects of the present invention. Application mode, and under the situation of not exceeding the patent scope of this case, replace other use steps and apply the present invention:
食道癌:Esophageal cancer:
将导管装置10从鼻腔置入食道。在外层元件14尚未胀缩的状态下,因无外加气囊的干扰,即能顺畅将导管装置10从鼻腔至入食道,故无需从口腔放入。导管装置10置入食道后,以胶带黏贴于鼻孔外固定。Catheter device 10 is inserted nasally into the esophagus. In the state where the outer element 14 has not yet expanded or contracted, the catheter device 10 can be smoothly inserted from the nasal cavity to the esophagus without the interference of an external air bag, so it does not need to be inserted from the oral cavity. After the catheter device 10 is inserted into the esophagus, it is fixed outside the nostrils with an adhesive tape.
将白管(lumen cath,图未示)置入导管装置10的管状结构11,直到最末端,以胶带将白管(图未示)与管状结构11黏贴固定。A white tube (lumen cath, not shown in the figure) is inserted into the tubular structure 11 of the catheter device 10 until the end, and the lumen cath (not shown in the figure) is glued and fixed to the tubular structure 11 with adhesive tape.
再将白管(图未示)开口端接上后荷式治疗仪103,放入可测量置入管腔内相对深度并且能在CT影像中显影的模拟射源。Then connect the open end of the white tube (not shown in the figure) to the back-loading therapeutic apparatus 103, and put in a simulated radiation source that can measure the relative depth in the lumen and can be visualized in the CT image.
撷取病人该部位的影像scout view(重组的平面影像),观看模拟射源的分布范围,对照治疗计划系统电脑断层影像重组的平面影像其肿瘤范围,决定导管装置10相对应膨胀的外层元件14位置与膨胀程度。因为本案导管装置10具有足够多的外层元件14(例:8个可胀缩的外层元件),即使是弥漫性肿瘤,置入导管装置后也不需要做任何移动,这使病人在无麻醉的情形下也能感觉舒适。Capture the image scout view (recombined planar image) of the patient’s part, watch the distribution range of the simulated radiation source, compare the tumor range of the planar image reconstructed from the computerized tomography image of the treatment planning system, and determine the corresponding expanded outer layer component of the catheter device 10 14 positions and degrees of expansion. Because the catheter device 10 of this case has enough outer layer elements 14 (for example: 8 expandable outer layer elements), even if it is a diffuse tumor, it does not need to do any movement after being placed in the catheter device, which enables the patient to Feel comfortable even under anesthesia.
将部分外层元件14膨胀后扫描电脑断层影像,确认膨胀大小适当,如有需要调整大小,在修改后重新扫描电脑断层影像。Part of the outer element 14 is inflated and then scanned for computerized tomography to confirm that the expansion is appropriate. If necessary, the size is adjusted, and the computerized tomography is re-scanned after modification.
将电脑断层影像传送至治疗计划系统,描绘外层元件14膨胀时的肿瘤位置和肿瘤范围,亦可描绘其周边正常组织(如肺部、心脏、脊髓等)。The computed tomography image is sent to the treatment planning system to depict the tumor location and tumor range when the outer element 14 is inflated, as well as its surrounding normal tissues (such as lungs, heart, spinal cord, etc.).
针对病人各种肿瘤大小形状,制作3D治疗计划(剂量计算),以确保肿瘤范围得到足够的剂量,并使正常组织的接收剂量在安全范围内。According to the various tumor sizes and shapes of patients, 3D treatment plans (dose calculation) are made to ensure that the tumor area receives sufficient doses and the normal tissue receives doses within a safe range.
执行治疗,施予照射。Treatment is performed, irradiation is administered.
直肠癌:rectal cancer:
从病患的肛门放入导管装置10至直肠,并以胶带黏贴于肛门外固定导管装置10。Put the catheter device 10 from the patient's anus to the rectum, and stick the catheter device 10 outside the anus with an adhesive tape.
放入白管(图未示)至导管装置10的管状结构11,直到最末端,以胶带将白管(图未示)与管状结构11黏贴固定。Put a white tube (not shown in the figure) into the tubular structure 11 of the catheter device 10 until the end, and stick the white tube (not shown in the figure) to the tubular structure 11 with adhesive tape.
再将白管(图未示)开口端接上后荷式治疗仪103,放入可测量置入管腔内相对深度并且能在CT影像中显影的模拟射源。Then connect the open end of the white tube (not shown in the figure) to the back-loading therapeutic apparatus 103, and put in a simulated radiation source that can measure the relative depth in the lumen and can be visualized in the CT image.
撷取病人该部位的影像scout view(重组的平面影像),观看模拟射源的分布范围,对照治疗计划系统电脑断层影像重组的平面影像其肿瘤范围,决定导管装置10相对应膨胀的外层元件14位置与膨胀程度。因为本案导管装置10具有足够多的外层元件14(例:8个可胀缩的外层元件),即使是弥漫性肿瘤,置入导管装置后也不需要做任何移动,这使病人在无麻醉的情形下也能感觉舒适。Capture the image scout view (recombined planar image) of the patient’s part, watch the distribution range of the simulated radiation source, compare the tumor range of the planar image reconstructed from the computerized tomography image of the treatment planning system, and determine the corresponding expanded outer layer component of the catheter device 10 14 positions and degrees of expansion. Because the catheter device 10 of this case has enough outer layer elements 14 (for example: 8 expandable outer layer elements), even if it is a diffuse tumor, it does not need to do any movement after being placed in the catheter device, which enables the patient to Feel comfortable even under anesthesia.
将部分外层元件14膨胀后扫描电脑断层影像,确认膨胀大小适当,如有需要调整大小,在修改后重新扫描电脑断层影像。Part of the outer element 14 is inflated and then scanned for computerized tomography to confirm that the expansion is appropriate. If necessary, the size is adjusted, and the computerized tomography is re-scanned after modification.
将电脑断层影像传送至治疗计划系统,描绘外层元件14膨胀时的肿瘤位置和肿瘤范围,亦可描绘其周边正常组织(女性如子宫卵巢;男性如摄护腺、膀胱等)。The computed tomography image is sent to the treatment planning system to depict the tumor location and tumor range when the outer element 14 expands, as well as its surrounding normal tissues (female such as uterus and ovary; male such as prostate and bladder, etc.).
针对病人各种肿瘤大小形状,制做3D治疗计划(剂量计算),以确保肿瘤范围得到足够的剂量,并使正常组织的接收剂量在安全范围内。According to various tumor sizes and shapes of patients, 3D treatment plans (dose calculations) are made to ensure that the tumor area receives sufficient doses and the dose received by normal tissues is within a safe range.
执行治疗,施予照射。Treatment is performed, irradiation is administered.
本发明不需要导引线的辅助、可在一次近接治疗中照射整段弥漫性肿瘤,不需要重复置放导管与放射源、可避免病患呼吸或移动导致导管与肿瘤之间相对位置的改变,影响治疗计划精准度;本案治疗食道癌时不需要自口腔中放入而毋需对病患施予麻醉,加上并非以外加气囊,而是具备可胀缩的外层元件14与节点单元15等元件达成治疗目的,没有一般外加气囊在进入体腔时会和体腔壁摩擦造成病患不适感甚至腔壁损伤,大大提升置入病患狭窄的腔体时的顺畅度,解决了现有技术的问题,达到了更好的效果。The present invention does not require the assistance of a guide wire, can irradiate the entire diffuse tumor in one brachytherapy, does not need to repeatedly place catheters and radiation sources, and can avoid changes in the relative position between the catheter and the tumor caused by breathing or movement of the patient , affecting the accuracy of the treatment plan; in this case, the treatment of esophageal cancer does not need to be inserted from the mouth and does not require anesthesia to the patient, and it is not an external air bag, but has an expandable outer layer element 14 and a node unit 15 and other components achieve the purpose of treatment, there is no general external airbag that will rub against the wall of the body cavity when entering the body cavity, causing discomfort to the patient or even damage to the cavity wall, which greatly improves the smoothness of insertion into the narrow cavity of the patient and solves the problem of the existing technology problems and achieve better results.
符号说明Symbol Description
导管装置10catheter set 10
管状结构11Tubular structure 11
射源12Source 12
流体流管结构13Fluid flow pipe structure 13
外层元件14Outer element 14
节点单元15node unit 15
控制元件16control element 16
开口17opening 17
远端方向18Distal Direction 18
近端方向19proximal direction 19
间段1ainterval 1a
空间1bSpace 1b
柱壁31column wall 31
通道32channel 32
中空处33Hollow 33
接着环部41Then ring part 41
外环结构51Outer ring structure 51
突出环部71Protruding ring part 71
肿瘤组织101Tumor Tissue 101
正常组织102Normal Tissue 102
后荷式治疗仪103After-load therapy device 103
肿瘤成像仪器104Tumor Imaging Instruments 104
肿瘤大小GTVtumor sizeGTV
扩散范围CTVDiffusion Range CTV
移动偏差范围ITVMobile Deviation Range ITV
治疗边界范围PTVTreatment Boundary Range PTV
Claims (14)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610431937.3A CN106039551A (en) | 2016-06-17 | 2016-06-17 | Catheter device and brachytherapy system |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610431937.3A CN106039551A (en) | 2016-06-17 | 2016-06-17 | Catheter device and brachytherapy system |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106039551A true CN106039551A (en) | 2016-10-26 |
Family
ID=57169139
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610431937.3A Pending CN106039551A (en) | 2016-06-17 | 2016-06-17 | Catheter device and brachytherapy system |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106039551A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017214956A1 (en) * | 2016-06-17 | 2017-12-21 | 贝克生医股份有限公司 | Catheter device and brachytherapy system |
WO2019113929A1 (en) * | 2017-12-15 | 2019-06-20 | 贝克生医股份有限公司 | Catheter device and brachytherapy system |
CN109925592A (en) * | 2017-12-15 | 2019-06-25 | 贝克生医股份有限公司 | A kind of conduit device and brachytherapy system |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4983167A (en) * | 1988-11-23 | 1991-01-08 | Harvinder Sahota | Balloon catheters |
EP1568397A1 (en) * | 2004-02-25 | 2005-08-31 | Acrostak Corp. | Balloon for brachytherapy and application of the balloon |
CN101861184A (en) * | 2007-08-29 | 2010-10-13 | 阿克罗斯塔克公司 | Method and kit for delivery of brachytherapy to a subject |
CN202387089U (en) * | 2011-10-09 | 2012-08-22 | 东南大学 | Multi-balloon esophagus catheter with adjustable length |
CN203263978U (en) * | 2013-05-20 | 2013-11-06 | 邱宝军 | Single-cavity tracheal and esophageal catheter |
WO2015153595A1 (en) * | 2014-04-02 | 2015-10-08 | Gc Medtech Llc | Internal body cavity therapeutic applicators and methods for using them |
-
2016
- 2016-06-17 CN CN201610431937.3A patent/CN106039551A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4983167A (en) * | 1988-11-23 | 1991-01-08 | Harvinder Sahota | Balloon catheters |
EP1568397A1 (en) * | 2004-02-25 | 2005-08-31 | Acrostak Corp. | Balloon for brachytherapy and application of the balloon |
CN101861184A (en) * | 2007-08-29 | 2010-10-13 | 阿克罗斯塔克公司 | Method and kit for delivery of brachytherapy to a subject |
CN202387089U (en) * | 2011-10-09 | 2012-08-22 | 东南大学 | Multi-balloon esophagus catheter with adjustable length |
CN203263978U (en) * | 2013-05-20 | 2013-11-06 | 邱宝军 | Single-cavity tracheal and esophageal catheter |
WO2015153595A1 (en) * | 2014-04-02 | 2015-10-08 | Gc Medtech Llc | Internal body cavity therapeutic applicators and methods for using them |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017214956A1 (en) * | 2016-06-17 | 2017-12-21 | 贝克生医股份有限公司 | Catheter device and brachytherapy system |
WO2019113929A1 (en) * | 2017-12-15 | 2019-06-20 | 贝克生医股份有限公司 | Catheter device and brachytherapy system |
CN109925592A (en) * | 2017-12-15 | 2019-06-25 | 贝克生医股份有限公司 | A kind of conduit device and brachytherapy system |
KR20200042456A (en) * | 2017-12-15 | 2020-04-23 | 브락스 바이오테크 컴퍼니 리미티드 | Catheter device and brachytherapy system |
JP2020526327A (en) * | 2017-12-15 | 2020-08-31 | 貝克生医股▲フン▼有限公司BRAXX Biotech Co., Ltd. | Conduit device and proximity treatment system |
CN109925592B (en) * | 2017-12-15 | 2022-02-01 | 贝克生医股份有限公司 | Catheter device and brachytherapy system |
JP7021801B2 (en) | 2017-12-15 | 2022-02-17 | 貝克生医股▲フン▼有限公司 | Vessel device and brachytherapy system |
KR102461914B1 (en) * | 2017-12-15 | 2022-11-01 | 브락스 바이오테크 컴퍼니 리미티드 | Catheter Devices and Brachytherapy Systems |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8734314B2 (en) | Method and kit for delivery of brachytherapy to a subject | |
US8961383B2 (en) | Intracavitary radiation system | |
US9283402B2 (en) | Apparatus and method for providing a double balloon breast brachytherapy device | |
US11944844B2 (en) | Internal body cavity therapeutic applicators and methods for using them | |
US20060020156A1 (en) | Therapeutic device | |
US12137882B2 (en) | Systems and methods for treating cancer using brachytherapy | |
US11116993B2 (en) | Catheter apparatus and brachytherapy system | |
CN106039551A (en) | Catheter device and brachytherapy system | |
WO2019113929A1 (en) | Catheter device and brachytherapy system | |
JP5618828B2 (en) | Method and kit for administering brachytherapy to a subject | |
US9498644B2 (en) | Apparatus for brachytherapy | |
TWI584836B (en) | A catheter apparatus? and system for brachytherapy | |
TWI678217B (en) | A catheter apparatus and system for brachytherapy | |
CN109925592B (en) | Catheter device and brachytherapy system | |
CN223126552U (en) | X-ray tracking and positioning device for pelvic radiotherapy | |
TR201911979A2 (en) | Intracavitary non-invasive multi-channel balloon brachytherapy applicator in the treatment of bladder cancer. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20161026 |
|
RJ01 | Rejection of invention patent application after publication |